•
XE
XERS
Xeris Biopharma Holdings, Inc. Common Stock
yahooPHARMACEUTICAL PREPARATIONS
--
Price Chart
Market Cap
1.26B
Volume
1.44M
52W High
$10.08
52W Low
$3.24
Open
$0.00
Prev Close
$7.61
Day Range
0.00 - 0.00
About Xeris Biopharma Holdings, Inc. Common Stock
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
Latest News
Xeris (XERS) Q2 Revenue Jumps 49%
The Motley Fool•Aug 7
Xeris Biopharma (XERS) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research•May 9
Strength Seen in MediWound (MDWD): Can Its 14.3% Jump Turn into More Strength?
Zacks Investment Research•Apr 17
Xeris Biopharma: Checking-In On One Of My 'Top Ideas'
Seeking Alpha•Mar 30
Why Xeris (XERS) Might Surprise This Earnings Season
Zacks Investment Research•Mar 5
Xeris (XERS) Up on Licensing Deal With Amgen to Develop Tepezza
Zacks Investment Research•Jan 11
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga•Jan 10
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
Benzinga•Jan 4